Pierre Fabre and Iktos team up to accelerate AI-driven cancer drug discovery
Iktos will deploy its AI-driven tools to accelerate the identification of optimized small-molecule candidates against a currently undisclosed oncology target
Iktos will deploy its AI-driven tools to accelerate the identification of optimized small-molecule candidates against a currently undisclosed oncology target
Sabitha highlighted the growing relevance of minimally invasive therapies in modern medicine
Artificial intelligence coupled with laboratory automation will transform how scientific work is performed
Projects selected for advancement will move forward through the Harvard Office of Technology Development’s processes for sponsored research agreements
BFF provides bookable fermentation upscaling capacity, process expertise, and quality procedures for pilot campaigns, generating decision-grade data without companies needing to build their own facilities
Backed by two CAP - accredited genomics labs in Delhi NCR and Mumbai, supporting oncology, reproductive health, neurology, transplant immunology, and rare diseases
The trial supports the potential for another chemotherapy backbone option that may be paired with encorafenib plus cetuximab in this patient population
The grant will fund ten new J.MD projects over the next three years, targeting multiple global health threats
The partnership aims to develop a first-in-class broad-spectrum antifungal to combat life-threatening invasive infections
Subscribe To Our Newsletter & Stay Updated